Literature DB >> 20462470

Swine influenza vaccines: current status and future perspectives.

Wenjun Ma1, Jürgen A Richt.   

Abstract

Swine influenza is an important contagious disease in pigs caused by influenza A viruses. Although only three subtypes of influenza A viruses, H1N1, H1N2 and H3N2, predominantly infect pigs worldwide, it is still a big challenge for vaccine manufacturers to produce efficacious vaccines for the prevention and control of swine influenza. Swine influenza viruses not only cause significant economic losses for the swine industry, but are also important zoonotic pathogens. Vaccination is still one of the most important and effective strategies to prevent and control influenza for both the animal and human population. In this review, we will discuss the current status of swine influenza worldwide as well as current and future options to control this economically important swine disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20462470     DOI: 10.1017/S146625231000006X

Source DB:  PubMed          Journal:  Anim Health Res Rev        ISSN: 1466-2523            Impact factor:   2.615


  18 in total

1.  Genetic characterization of swine influenza viruses (H3N2) isolated from Minnesota in 2006-2007.

Authors:  Sandeep R P Kumar; Laure Deflube; Moanaro Biswas; Raghunath Shobana; Subbiah Elankumaran
Journal:  Virus Genes       Date:  2011-05-21       Impact factor: 2.332

2.  Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease.

Authors:  Amy L Vincent; Wenjun Ma; Kelly M Lager; Jürgen A Richt; Bruce H Janke; Matthew R Sandbulte; Philip C Gauger; Crystal L Loving; Richard J Webby; Adolfo García-Sastre
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

3.  DNA-epitope vaccine provided efficient protection to mice against lethal dose of influenza A virus H1N1.

Authors:  Huiling Wei; Stephen D Lenz; David H Thompson; Roman M Pogranichniy
Journal:  Viral Immunol       Date:  2014-01-09       Impact factor: 2.257

4.  DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.

Authors:  J Patrick Gorres; Kelly M Lager; Wing-Pui Kong; Michael Royals; John-Paul Todd; Amy L Vincent; Chih-Jen Wei; Crystal L Loving; Eraldo L Zanella; Bruce Janke; Marcus E Kehrli; Gary J Nabel; Srinivas S Rao
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

5.  First report of seroprevalence of swine influenza A virus in Tibetan pigs in Tibet, China.

Authors:  Guo-Hua Liu; Dong-Hui Zhou; Wei Cong; Xiao-Xuan Zhang; Xin-Chun Shi; Ciren Danba; Si-Yang Huang; Xing-Quan Zhu
Journal:  Trop Anim Health Prod       Date:  2013-08-18       Impact factor: 1.559

Review 6.  Swine influenza virus: Current status and challenge.

Authors:  Wenjun Ma
Journal:  Virus Res       Date:  2020-08-13       Impact factor: 3.303

7.  The Molecular Determinants of Antibody Recognition and Antigenic Drift in the H3 Hemagglutinin of Swine Influenza A Virus.

Authors:  Eugenio J Abente; Jefferson Santos; Nicola S Lewis; Phillip C Gauger; Jered Stratton; Eugene Skepner; Tavis K Anderson; Daniela S Rajao; Daniel R Perez; Amy L Vincent
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

8.  Rapid control of pandemic H1N1 influenza by targeting NKT-cells.

Authors:  Bianca L Artiaga; Guan Yang; Tarun E Hutchinson; Julia C Loeb; Jürgen A Richt; John A Lednicky; Shahram Salek-Ardakani; John P Driver
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

Review 9.  Optimal Use of Vaccines for Control of Influenza A Virus in Swine.

Authors:  Matthew R Sandbulte; Anna R Spickler; Pamela K Zaabel; James A Roth
Journal:  Vaccines (Basel)       Date:  2015-01-30

10.  A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.

Authors:  Marie Borggren; Jens Nielsen; Ingrid Karlsson; Tina S Dalgaard; Ramona Trebbien; James A Williams; Anders Fomsgaard
Journal:  Vaccine       Date:  2016-05-19       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.